Mayo Clinic Researchers Report Research in Non-Small Cell Lung Cancer (Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report).

Předmět:	NON-small-cell lung carcinoma IMMUNE checkpoint inhibitors IPILIMUMAB HEPATOTOXICOLOGY
Zdroj:	Cancer Weekly; 8/15/2023, p446-446, 1p
Abstrakt:	Baseline demographics were comparable between patients with and without grade 3 hepatotoxicity, except for presence of CNS metastases and time from prior immune checkpoint inhibitor (ICI) treatment. Cancer, Gastroenterology, Health and Medicine, Lung Cancer, Lung Diseases and Conditions, Lung Neoplasms, Non-Small Cell Lung Cancer, Oncology, Risk and Prevention Keywords: Cancer; Gastroenterology; Health and Medicine; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Non-Small Cell Lung Cancer; Oncology; Risk and Prevention EN Cancer Gastroenterology Health and Medicine Lung Cancer Lung Diseases and Conditions Lung Neoplasms Non-Small Cell Lung Cancer Oncology Risk and Prevention 446 446 1 08/14/23 20230815 NES 230815 2023 AUG 15 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Researchers detail new data in non-small cell lung cancer. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu